Stock listing

TPEx:6586 CHO Pharma, Inc. (醣基) 股價

Follow CHO Pharma, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6586

$63.70 TWD -8.50 (-11.8%)

Close on Nov 20, 2026

Past year +112.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$62.00 – $72.80 TWDNov 20, 2026
Volume
789,967 sharesNov 20, 2026
Market cap
$13.63B TWDAt the close on Nov 20, 2026 · price × 214.0M shares outstanding
52-week range
$22.75 – $148.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$49.66M TWDMedian day 394,061 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
CHO Pharma, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6586 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$63.70-8.50-11.8%$72.80$72.80$62.00789,967
$72.20-7.60-9.5%$80.60$80.60$71.30458,210
$79.80-4.20-5.0%$85.50$85.80$77.90394,061
$84.00-5.70-6.4%$89.80$92.30$82.70648,505
$89.70+13.10+17.1%$76.60$97.00$76.601,379,124
$76.60+1.40+1.9%$76.90$76.90$73.80329,746
$75.20-0.80-1.1%$77.00$77.60$73.90440,053
$76.00+0.80+1.1%$75.00$80.60$73.00392,259
$75.200.000.0%$75.70$76.50$70.10421,357
$75.20+0.50+0.7%$74.30$80.50$73.10464,821
$74.70-3.50-4.5%$75.00$81.60$61.801,074,637
$78.20-10.10-11.4%$88.50$89.60$76.80600,485
$88.30-2.00-2.2%$89.00$91.50$84.20500,883
$90.30-8.00-8.1%$98.30$98.90$85.201,031,247
$98.30-1.20-1.2%$100.00$100.50$97.70429,007
$99.50-4.00-3.9%$101.50$103.00$99.00501,685
$103.500.000.0%$104.50$104.50$101.50179,187
$103.500.000.0%$106.00$109.00$102.50284,778
$103.50-2.50-2.4%$108.00$108.00$103.00306,765
$106.000.000.0%$106.00$106.00$106.000
$106.00-8.50-7.4%$114.00$114.00$105.00560,735
$114.50+10.00+9.6%$106.00$118.50$105.50766,669
$104.50+0.50+0.5%$104.00$105.50$102.50165,653
$104.00-3.00-2.8%$107.50$108.00$102.00193,943
$107.00+1.50+1.4%$107.50$108.00$105.00108,777
$105.50-2.00-1.9%$108.00$108.50$104.50262,973
$107.50-2.50-2.3%$108.00$112.00$106.50274,129
$110.00-4.50-3.9%$112.00$114.50$108.00411,606
$114.50-0.50-0.4%$115.50$116.00$112.50251,836
$115.00+0.50+0.4%$115.50$116.00$113.50201,608
$114.50-1.50-1.3%$114.50$116.50$113.50315,111
$116.00-3.50-2.9%$122.00$124.50$113.50845,447
$119.50+3.50+3.0%$117.50$125.50$115.501,080,808
$116.00-0.50-0.4%$115.00$120.50$113.00503,960
$116.50-4.50-3.7%$120.00$121.50$115.50837,343
$121.00-4.50-3.6%$124.50$127.00$120.50815,048
$125.50+21.50+20.7%$104.50$131.00$104.502,266,115
$104.00+4.00+4.0%$100.50$106.00$98.70609,174
$100.00-0.50-0.5%$101.00$101.50$99.00277,671
$100.50-0.50-0.5%$101.50$102.00$99.70218,896
$101.00+1.00+1.0%$100.50$102.50$99.70137,968
$100.00-5.00-4.8%$104.00$106.00$100.00491,900
$105.00+4.50+4.5%$102.00$110.50$99.70673,596
$100.50+1.90+1.9%$100.00$102.00$99.50223,939
$98.60-1.90-1.9%$101.00$101.00$98.60231,059
$100.500.000.0%$101.00$102.50$99.10155,092
$100.50-2.00-2.0%$101.50$102.50$99.00334,554
$102.50-1.50-1.4%$105.50$105.50$100.50306,379
$104.00-1.50-1.4%$105.50$111.00$102.50440,033
$105.50+4.50+4.5%$100.00$113.50$100.00654,096
$101.00+0.50+0.5%$100.50$102.50$99.00352,315
$100.50-4.00-3.8%$105.00$105.50$98.701,197,051
$104.50-5.00-4.6%$110.50$111.50$103.50881,843
$109.50-0.50-0.5%$110.00$113.00$109.00321,377
$110.000.000.0%$109.00$111.50$108.50275,349
$110.00+1.00+0.9%$108.50$114.00$108.00516,933
$109.00+0.50+0.5%$109.00$111.50$108.50211,202
$108.50-1.50-1.4%$111.50$112.00$108.50478,247
$110.00-2.00-1.8%$112.00$114.00$109.50393,553
$112.00-1.00-0.9%$113.00$113.00$110.50160,801
$113.00+1.50+1.3%$112.00$114.00$110.50298,066
$111.50+1.00+0.9%$114.50$114.50$110.50217,075
$110.50-2.00-1.8%$113.00$115.00$109.50353,638
Ticker
TPEx:6586
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

CHO Pharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 8,157× against a median of 15.8×: the highest of 7 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$11.67B TWD
P/E
Loss
EV/sales
8,157×
EV/EBITDA
Negative EBITDA
Price/book
5.7×
Gross margin
74.5%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CHO Pharma, Inc. · TPEX:6586US$413.6MUS$354.2Mn/a8,157×n/a5.7×n/a0.0×n/a
Indaptus Therapeutics, Inc. · NASDAQ:INDPUS$433.2MUS$402.6Mn/an/an/a41.9×n/a0.0×1.77
LongBio Pharma (Suzhou) Co., Ltd. Class H · HKEX:1779US$430.7MUS$402.1Mn/an/an/a20.5×n/a0.0×n/a
Ovid Therapeutics Inc. · NASDAQ:OVIDUS$429.7MUS$305.4Mn/a210×n/a2.2×n/a0.1×1.37
Arvinas, Inc. · NASDAQ:ARVNUS$423.0M−US$135.0Mn/a−0.5×n/a0.8×−3.5%0.0×1.25
Prothena Corporation plc · NASDAQ:PRTAUS$422.1MUS$157.0Mn/a3.0×n/a1.6×−45.4%0.0×0.96
TaiMed Biologics Inc. · TPEX:4147US$421.4MUS$385.5Mn/a20.5×n/a3.8×−22.4%0.1×n/a
Tectonic Therapeutic, Inc. · NASDAQ:TECXUS$413.5MUS$178.9Mn/an/an/a1.8×n/a0.0×0.95
Jacobio Pharmaceuticals Group Co., Ltd. · HKEX:1167US$401.1MUS$173.5Mn/a22.2×n/a2.0×−272.7%0.1×n/a
Candel Therapeutics, Inc. · NASDAQ:CADLUS$395.4MUS$193.8Mn/an/an/a3.0×n/a0.0×2.03
Ever Supreme Bio Technology Co., Ltd. · TPEX:6712US$394.8MUS$362.8M27.5×11.1×23.9×4.6×43.8%0.0×n/a
Median of the othersUS$421.7MUS$249.6M27.5×15.8×23.9×2.6×−22.4%0.0×1.31

Team and board

Officers

OfficerRole
Chung-Yi WuPresident, CEO

Board

DirectorRole
Chao-Long ChenChairman
Chung-Yi WuPresident, CEO
Jeng-Jiann ChiuIndependent Director
Richard M. TsaiDirector
Shuan-Ta LiuIndependent Director
Shun-Ling ChenDirector
Sung-Liang YuIndependent Director

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue1.43M3.58M060.0K3.57M138.0K297.0K
Cost of revenue365.0K1.87M01.00K211.0K71.0K119.0K
Gross profit1.07M1.71M059.0K3.36M67.0K178.0K
Research and development286.9M219.1M239.4M326.1M193.5M287.9M344.6M
Selling, general and administrative40.1M31.9M21.5M24.9M20.3M21.7M24.7M
Operating income-325.8M-249.3M-306.0M-338.1M-205.3M-296.1M-369.2M
Depreciation and amortization26.7M25.9M28.3M39.9M39.1M41.2M34.1M
EBITDA-299.1M-223.4M-277.7M-298.2M-166.3M-254.8M-335.1M
Interest expense406.0K679.0K77.0K301.0K576.0K775.0K
Income before tax-290.0M-212.2M-306.1M-338.4M-205.9M-296.8M-358.4M
Net income-290.0M-212.2M-306.1M-338.4M-205.9M-296.8M-358.4M
Earnings per share, basic-1.36-0.99-1.60-1.84-1.12-1.62-1.96

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents52.1M21.8M203.8M505.7M778.0M986.4M1.26B
Short-term investments2.01B2.34B2.40B538.9M538.9M538.9M538.9M
Receivables0751.0K0063.0K
Inventory1
Current assets2.12B2.42B2.64B1.08B1.34B1.55B1.82B
Total assets2.57B2.88B3.09B1.60B1.89B2.14B2.43B
Current liabilities109.1M116.2M106.0M168.9M133.2M149.2M132.7M
Total debt11.7M25.6M38.3M29.0M
Total liabilities109.1M132.6M110.8M173.7M149.7M179.7M29.0M
Shareholders' equity2.46B2.75B2.98B1.43B1.74B1.96B2.26B
Shares outstanding214.0M214.0M191.3M184.0M183.9M183.7M183.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-279.6M-217.4M-291.1M-249.5M-193.5M-248.7M-266.7M
Capital spending-11.7M-5.49M-2.00M-9.40M-2.64M-22.2M-11.4M
Free cash flow-291.3M-222.9M-293.1M-258.9M-196.1M-270.9M-278.2M
Cash from financing1.85B-13.9M-11.3M-9.59M8.81M
Change in cash30.3M-182.0M-301.9M-272.3M-208.4M-278.1M-276.6M

Open Financials

Cap table

Built by 6ix from CHO Pharma, Inc.’s releases

Common shares
214,010,500
Fully diluted
214,010,500

Fully diluted

LineShares
Common shares214,010,500

Share count over time

CountShares
Nov 22, 2026214,010,500

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
鑽石生技投資(股)公司30.9M14.4%Oct 31, 2026
中央研究院24M11.2%Oct 31, 2026
吳宗益6.09M2.8%Oct 31, 2026
蔡明興3.31M1.5%Oct 31, 2026
朱國慶30,0000.01%Oct 31, 2026
陳旦生4,000<0.01%Oct 31, 2026
尤斯薇100<0.01%Oct 31, 2026
蔡文晃00.00%Oct 31, 2026
裘正健00.00%Oct 31, 2026
孟子青00.00%Oct 31, 2026
All 17 holders
HolderSharesOf the companyAs of
陳肇隆00.00%Oct 31, 2026
程微倚00.00%Oct 31, 2026
俞松良00.00%Oct 31, 2026
吳詩婷00.00%Oct 31, 2026
陳舜伶00.00%Oct 31, 2026
馬寶琳00.00%Oct 31, 2026
劉玄達00.00%Oct 31, 2026

Funds

HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF36,921US$154KJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chao-Long ChenChairman · Since at least Nov 5, 2026
Chung-Yi WuPresident, CEO · Since at least Nov 5, 2026
Jeng-Jiann ChiuIndependent Director · Since at least Nov 5, 2026
Richard M. TsaiDirector · Since at least Nov 5, 2026
Shuan-Ta LiuIndependent Director · Since at least Nov 5, 2026
Shun-Ling ChenDirector · Since at least Nov 5, 2026
Sung-Liang YuIndependent Director · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about CHO Pharma, Inc.